Reports
Sale
Global Wearable Injectors Market Size, Share, Growth, Trends, Forecast: By Type: On-Body Injectors, Off-Body Injectors; By Therapy: Oncology, Autoimmune Disease, Diabetes, Cardiovascular Disease, Others; By End User: Hospitals, Diagnostic Centers, Home Care, Others; Regional Analysis; Market Dynamics; Supplier Landscape; 2023-2031
Global Wearable Injectors Market Outlook
The global wearable injectors market size reached a value of around USD 7.1 billion in 2022, driven by the rising prevalence of chronic disorders. The market is further expected to grow at a CAGR of 11.9% during the forecast period of 2023-2031, likely to attain a value of around USD 19.4 billion by 2031.
Wearable Injectors: Introduction
Wearable injectors refer to drug delivery devices that are used to deliver drug doses to the body. These drugs are delivered automatically on pre-set doses to the patient on set intervals, which is administered by the physician.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Wearable Injectors Market
The growth of the market is significantly being driven by the rising prevalence of chronic diseases like diabetes and cancer, among others. The growth of the market is also being driven by the rapid technological advancements in the healthcare sectors, along with the growing emphasis of the governments on improved healthcare infrastructure and facilities. Higher investment and funding by the governments and healthcare organisations are also providing a significant impetus to the growth of the market.
Global Wearable Injectors Market Analysis
Based on type, the market is divided into type, therapy, end user, and region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Type
- On-Body Injectors
- Off-Body Injectors
Market Breakup by Therapy
- Oncology
- Autoimmune Disease
- Diabetes
- Cardiovascular Disease
- Others
Market Breakup by End User
- Hospitals
- Diagnostic Centres
- Home Care
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Wearable Injectors Market Scenario
The market for wearable injectors has been witnessing robust growth and is anticipated to continue witnessing demand in the coming years with the rapidly developing healthcare sector. Among the regional markets, North America is anticipated to lead the global market as the region has the highest presence of the key players.
Apart from North America, Asia Pacific is also anticipated to register significant growth in the coming years owing to the rising prevalence of chronic conditions in the region, especially amongst the geriatric population. The favourable policies by the government for the use of these devices is likely to bolster the growth of the market.
Competitive Landscape
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global wearable injectors market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- Amgen
- Becton
- Dickinson and Company
- Dexcom, Inc.
- Enable Injections
- Insulet Corporation
- Sensile Medical
- Tandem Diabetes Care
- Ypsomed
- Johnson & Johnson Services
- F. Hoffmann-La Roche Ltd
- Unilife Corporation
- SteadyMed Therapeutics
- Insulet Corporation
- CeQur SA
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
|
Breakup by Type |
|
| Breakup by Therapy |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Wearable Injectors Market Overview
3.1 Global Wearable Injectors Market Historical Value (2016-2022)
3.2 Global Wearable Injectors Market Forecast Value (2023-2031)
4 Global Wearable Injectors Market Landscape
4.1 Wearable Injectors: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Wearable Injectors: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Global Wearable Injectors Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Wearable Injectors Market Segmentation
6.1 Global Wearable Injectors Market by Type
6.1.1 Market Overview
6.1.2 On-Body Injectors
6.1.3 Off-Body Injectors
6.2 Global Wearable Injectors Market by Therapy
6.2.1 Market Overview
6.2.2 Oncology
6.2.3 Autoimmune Disease
6.2.4 Diabetes
6.2.5 Cardiovascular Disease
6.2.6 Others
6.3 Global Wearable Injectors Market by End User
6.3.1 Hospitals
6.3.2 Diagnostic Centers
6.3.3 Home Care
6.3.4 Others
6.4 Global Wearable Injectors Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Wearable Injectors Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Wearable Injectors Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Wearable Injectors Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Wearable Injectors Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Wearable Injectors Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Amgen
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Becton
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Dickinson and Company
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Dexcom, Inc.
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Enable Injections
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Insulet Corporation
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Sensile Medical
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Tandem Diabetes Care
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Ypsomed
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Johnson & Johnson Services
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 F. Hoffmann-La Roche Ltd
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Unilife Corporation
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 SteadyMed Therapeutics
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 Insulet Corporation
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 CeQur SA
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
19 Wearable Injectors - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of USD 7.1 billion in 2022.
The market is anticipated to grow at a CAGR of 11.91% during the forecast period of 2023-2031 to attain a value of around USD 19.4 billion by 2031.
The growth of the market is driven by factors like rising prevalence of chronic disorders and the rapid technological advancements.
The key trends which are bolstering the market growth include the rising investment and funding by the government.
The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The types can be categorized into on-body injectors and off-body injectors.
The therapies in the market include oncology, autoimmune disease, diabetes, and cardiovascular disease, among others.
The end-users in the market include hospitals, diagnostic centres, and home care, among others.
The key players in the market can be categorised into Amgen, Becton, Dickinson and Company, Dexcom, Inc., Enable Injections, Insulet Corporation, Sensile Medical, Tandem Diabetes Care, Ypsomed, Johnson & Johnson Services, F. Hoffmann-La Roche Ltd, Unilife Corporation, SteadyMed Therapeutics, Insulet Corporation, and CeQur SA.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999$5999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER